Free Trial
Ends Tomorrow! Last Chance to Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim $100 Off
Claim MarketBeat All Access Sale Promotion

Laidlaw's Rating of Palatin Technologies on 12/12/2025

On December 12, 2025, Laidlaw updated its outlook on Palatin Technologies (NYSEAMERICAN:PTN) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Laidlaw

DateCompanyAction
4/15/2026
Novogen Limited stock logo
KZIA
Novogen
Initiated Coverage
11/20/2025
Femasys Inc. stock logo
FEMY
Femasys
Initiated Coverage
11/6/2025
Evoke Pharma, Inc. stock logo
EVOK
Evoke Pharma
Downgrade
6/6/2025
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
Initiated Coverage
4/17/2025
icad inc. stock logo
ICAD
icad
Reiterated Rating
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Boost Price Target
More Ratings From Laidlaw